
Experience the Hope: How Sanofi’s Groundbreaking Drug Slows Down Heart Valve Disease Progression (Reuters, 2025)
A New Hope for Aortic Valve Stenosis: Sanofi’s Experimental Drug Shines in Clinical Trials Heart diseases are a leading cause of mortality worldwide, and one of the most common conditions that affect the heart valves is aortic valve stenosis. This condition occurs when the aortic valve, which is responsible for allowing blood to flow from…